Cross-Disciplinary Convergence

Operates the Stem for Life Foundation as a subsidiary to advocate for the potential of cell and gene therapies through education, outreach, and thought leadership.

Authored and published influential books including "The Healing Cell" (2011) and "Cells Are the New Cure" (2017) to advance public and professional understanding of cell-based therapies.

Establishes and expands a global network of scientists, physicians, medical specialists, faith leaders, academic institutions, patient advocates, philanthropists, and industry professionals to address critical health issues.

Organizes international conferences and global think tank events, including the series of International Vatican Conferences and the "Inflammation: Shared Pathways in Diverse Diseases" event, to bring together experts and advance dialogue on regenerative medicine, cell and gene therapies, and inflammation.

Hosts expert forums and dialogues that integrate science, medicine, theology, and philosophy to explore the intersection of faith and health.

Produces and distributes public service announcements (PSAs) featuring celebrities and athletes in multiple languages, achieving over 535 million impressions through radio and TV airings to promote public health, particularly during the COVID-19 pandemic.

Produces a monthly newsletter and interview series that highlights breakthroughs, innovations, and technologies addressing unmet medical needs in human health.

Carries out original scientific research on infectious diseases including HIV, SARS-CoV-2, chikungunya, Zika, Lassa fever, and tuberculosis, with a focus on developing vaccines, monoclonal antibodies, diagnostic tools, and gene therapies. Includes clinical trials of mRNA vaccines and development of biosensors for pathogen detection.

Provides financial support for scientific research conducted by the Institut Pasteur in Paris and across its global network, including work on infectious diseases, vaccine development, and public health initiatives. This includes targeted funding during global health crises such as the COVID-19 pandemic.

Awards grants to support postdoctoral and early-career researchers, particularly from the U.S., Canada, and the UK, to conduct biomedical research at the Institut Pasteur in Paris or within the Pasteur Network. Includes named fellowship programs such as the Sir Dennis and Lady Gillings Global Health Fellowship and the Lady Mireille & Sir Dennis Gillings Global Public Health Fellowship.

Operates and funds international exchange programs that facilitate scientific collaboration between U.S. researchers and the Institut Pasteur, including structured fellowship placements and mentorship opportunities to strengthen bilateral research partnerships.

Provides clinical and ambulatory training opportunities for medical students through affiliations with over 85 hospitals and health systems in the United States, Canada, and the United Kingdom.

Fosters collaborative relationships between international scholars and regional scientists to support research initiatives and strengthen global research capacity.

Graduates medical students through its School of Medicine, with over 25,000 graduates since 1981, and supports US residency placement, achieving a 94% placement rate for graduates over the five-year period from 2021 to 2025, including over 800 placements in 2026 alone.

Conducts multidisciplinary research and offers research opportunities for medical students through the Medical Student Research Initiative, aligned with broader programs focused on health and sustainable environmental development.

Hosts pre-health advisors for three-day campus visits in Grenada, covering airfare, hotel, meals, and transportation, and includes tours of academic and student life facilities as well as meetings with faculty and students from the School of Medicine and School of Veterinary Medicine.

Funds collaborative research on the role and application of Propionibacterium acnes in atopic dermatitis, involving Huashan Hospital, Fudan University, and the University of California at San Francisco.

Funds a multi-year research study on aging immunity and viral infections in older adults at Johns Hopkins University.